Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -50.20% is in line with its 5-year average of -49.54%, around the middle of its 5-year range (-91.05%–-17.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.41% above its 12-month average of -50.92%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -50.20%.
RETURN ON INVESTED CAPITAL (ROIC)
-50.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-50.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-43.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-49.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-65.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+1.41%
CURRENT VS 3Y AVG
-14.58%
CURRENT VS 5Y AVG
-1.34%
CURRENT VS 10Y AVG
+23.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
-49.35%
vs the sector median at left
Ocular Therapeutix, Inc.
Market Cap
$1.63B
Return on Invested Capital (ROIC)
-50.20%
TTM Avg
-50.92%
3Y Avg
-43.82%
5Y Avg
-49.54%
Market Cap
$1.62B
Return on Invested Capital (ROIC)
9.26%
TTM Avg
2.84%
3Y Avg
1.55%
5Y Avg
-0.61%
Market Cap
$1.65B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-17.29%
3Y Avg
-24.58%
5Y Avg
-25.54%
Market Cap
$1.61B
Return on Invested Capital (ROIC)
-47.99%
TTM Avg
-42.50%
3Y Avg
-275.02%
5Y Avg
-275.02%
Market Cap
$1.59B
Return on Invested Capital (ROIC)
2.43%
TTM Avg
0.22%
3Y Avg
-0.18%
5Y Avg
1.11%
Market Cap
$1.70B
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-54.60%
3Y Avg
-46.39%
5Y Avg
-38.46%
Market Cap
$1.70B
Return on Invested Capital (ROIC)
-42.87%
TTM Avg
-29.07%
3Y Avg
-38.98%
5Y Avg
-32.39%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
8.44%
3Y Avg
9.74%
5Y Avg
16.58%
Market Cap
$1.73B
Return on Invested Capital (ROIC)
10.03%
TTM Avg
-6.49%
3Y Avg
-7.14%
5Y Avg
-3.83%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.63B | -50.20% | -50.92% | -43.82% | -49.54% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 9.26% | 2.84% | 1.55% | -0.61% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -7.32% | -17.29% | -24.58% | -25.54% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | -47.99% | -42.50% | -275.02% | -275.02% |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 2.43% | 0.22% | -0.18% | 1.11% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.70B | -54.45% | -54.60% | -46.39% | -38.46% |
| Personalis, Inc. (PSNL)vs › | $1.70B | -42.87% | -29.07% | -38.98% | -32.39% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 8.36% | 8.44% | 9.74% | 16.58% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 10.03% | -6.49% | -7.14% | -3.83% |
| uniQure N.V. (QURE)vs › | $1.53B | -22.55% | -30.11% | -30.00% | -19.97% |
ROIC
-50.2%
ROE
-58.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -50.20% |
| 2026-03-31 | -43.52% |
| 2025-12-31 | -35.66% |
| 2025-09-30 | -69.37% |
| 2025-06-30 | -55.86% |
| 2025-03-31 | -55.46% |
| 2024-12-31 | -41.24% |
| 2024-09-30 | -31.11% |
| 2024-06-30 | -23.50% |
| 2024-03-31 | -17.77% |
| 2023-12-31 | -37.94% |
| 2023-09-30 | -64.17% |
| 2023-06-30 | -91.05% |
| 2023-03-31 | -84.33% |
| 2022-12-31 | -66.72% |
| 2022-09-30 | -59.81% |
| 2022-06-30 | -51.26% |
| 2022-03-31 | -46.22% |
| 2021-12-31 | -43.71% |
| 2021-09-30 | -38.60% |
| 2021-06-30 | -32.90% |
| 2021-03-31 | -29.68% |
| 2020-12-31 | -25.81% |
| 2020-09-30 | -85.75% |
| 2020-06-30 | -80.98% |
| 2020-03-31 | -129.68% |
| 2019-12-31 | -128.62% |
| 2019-09-30 | -105.12% |
| 2019-06-30 | -92.14% |
| 2019-03-31 | -70.33% |
| 2018-12-31 | -92.54% |
| 2018-09-30 | -86.65% |
| 2018-06-30 | -84.98% |
| 2018-03-31 | -85.78% |
| 2017-12-31 | -130.23% |
| 2017-09-30 | -107.37% |
| 2017-06-30 | -80.77% |
| 2017-03-31 | -58.46% |
| 2016-12-31 | -63.54% |
| 2016-09-30 | -52.81% |
| 2016-06-30 | -50.11% |
| 2016-03-31 | -43.51% |
| 2015-12-31 | -36.40% |
| 2015-09-30 | -31.11% |
| 2015-06-30 | -25.01% |
| 2015-03-31 | -40.79% |
| 2014-12-31 | -36.78% |
| 2014-09-30 | -28.53% |
| 2014-06-30 | -95.41% |
| 2014-03-31 | -126.63% |
| 2013-12-31 | -73.27% |
